Design Therapeutics, Inc. — Director's Dealing 2021

Jun 16, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Design Therapeutics, Inc. (DSGN)
CIK: 0001807120
Period of Report: 2021-06-15

Reporting Person: Prasad Deepa (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1479946	Indirect
Common Stock	337327	Indirect

Footnotes

F1: The reported securities are held directly by WRG Healthcare Fund I, LP. The reporting person is a member of the investment committee of WRG Healthcare Fund I, LP and may be deemed to have power to vote or dispose of these shares. The reporting person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

F2: The reported securities are held directly by WRG HCD1, LLC. The reporting person is a member of WRG HCD1, LLC and may be deemed to have power to vote or dispose of these shares. The reporting person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.